EU Bans Indian Factory For GMP Failures In Making Generic Plavix
This article was originally published in PharmAsia News
Executive Summary
An Indian factory producing drugs for Acino of Switzerland is the source of a recall of generics of Plavix (clopidogrel) anti-clotting drug in the European Union